Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review

被引:23
作者
Kim, Sang Jin [1 ,2 ]
Kim, Jong Man [3 ]
机构
[1] Korea Univ, Dept Surg, Coll Med, Seoul, South Korea
[2] Korea Univ, Div Hepatobiliopancreas & Transplant Surg, Ansan Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea
关键词
Hepatocellular carcinoma; Liver transplantation; Recurrence; POSITRON-EMISSION-TOMOGRAPHY; ALPHA-FETOPROTEIN; TUMOR RECURRENCE; CLINICAL IMPACT; MILAN CRITERIA; PORTAL-VEIN; OUTCOMES; CANCER; RISK; HCC;
D O I
10.3350/cmh.2022.0060
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplantation (LT) is one of the most effective treatments for hepatocellular carcinoma (HCC). Although LT eliminates HCC and greatly reduces recurrence, some patients experience recurrence after LT. Criteria and models for screening patients with a high probability of HCC recurrence after LT, starting with the Milan criteria, have been published. These models have changed over time, but a standard has not been established. We summarized HCC prediction models after LT by focusing on the application of radiologic, serologic, and pathologic factors and recent trends. This review will look at studies that are based on living donor LT and deceased donor LT, as well as studies that downstaging procedures have been performed preoperatively. This ultimately aims to help make decisions for evaluating the HCC state and selecting candidates for LT according to the circumstances of each transplantation center.
引用
收藏
页码:739 / 753
页数:15
相关论文
共 76 条
[1]   Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients [J].
Abdel-Wahab, Reham ;
Hassan, Manal M. ;
George, Bhawana ;
Pestana, Roberto Carmagnani ;
Xiao, Lianchun ;
Lacin, Sahin ;
Yalcin, Suayib ;
Shalaby, Ahmed S. ;
Al-Shamsi, Humaid O. ;
Raghav, Kanwal ;
Wolff, Robert A. ;
Yao, James C. ;
Girard, Lauren ;
Haque, Abedul ;
Duda, Dan G. ;
Dima, Simona ;
Popescu, Irinel ;
Elghazaly, Hesham A. ;
Vauthey, Jean-Nicolas ;
Aloia, Thomas A. ;
Tzeng, Ching-Wei ;
Chun, Yun Shin ;
Rashid, Asif ;
Morris, Jeffrey S. ;
Amin, Hesham M. ;
Kaseb, Ahmed O. .
ONCOLOGY, 2020, 98 (12) :836-846
[2]   Systematic review: risk prediction models for recurrence of hepatocellular carcinoma after liver transplantation [J].
Al-Ameri, Abdulahad Abdulrab Mohammed ;
Wei, Xuyong ;
Wen, Xue ;
Wei, Qiang ;
Guo, Haijun ;
Zheng, Shusen ;
Xu, Xiao .
TRANSPLANT INTERNATIONAL, 2020, 33 (07) :697-712
[3]   Micro RNA Expression Profiles as Adjunctive Data to Assess the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation [J].
Barry, C. T. ;
D'Souza, M. ;
McCall, M. ;
Safadjou, S. ;
Ryan, C. ;
Kashyap, R. ;
Marroquin, C. ;
Orloff, M. ;
Almudevar, A. ;
Godfrey, T. E. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (02) :428-437
[4]   The MELD score in patients awaiting liver transplant: Strengths and weaknesses [J].
Bernardi, Mauro ;
Gitto, Stefano ;
Biselli, Maurizio .
JOURNAL OF HEPATOLOGY, 2011, 54 (06) :1297-1306
[5]   Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease [J].
Bertot, Luis Calzadilla ;
Adams, Leon A. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (02) :179-187
[6]   Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis [J].
Bozorgzadeh, Adel ;
Orloff, Mark ;
Abt, Peter ;
Tsoulfas, Georgios ;
Younan, Durald ;
Kashyap, Randeep ;
Jain, Ashok ;
Mantry, Parvez ;
Maliakkal, Benedict ;
Khorana, Alok ;
Schwartz, Seymour .
LIVER TRANSPLANTATION, 2007, 13 (06) :807-813
[7]   Clinical impact of anatomical resection on long-term outcomes after hepatectomy for primary solitary hepatocellular carcinoma with or without preoperative positron emission tomography positivity [J].
Cho, Chan Woo ;
Kim, Jong Man ;
Lee, Beom-Hui ;
Lee, Dong-Shik ;
Yun, Sung-Su ;
Choi, Gyu-Seong ;
Joh, Jae-Won .
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
[8]   Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation [J].
Cho, Jai Young ;
Suh, Kyung-Suk ;
Shin, Woo Young ;
Lee, Hae Won ;
Yi, Nam-Joon ;
Lee, Kuhn Uk .
WORLD JOURNAL OF SURGERY, 2008, 32 (08) :1731-1737
[9]   Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma [J].
Cillo, U ;
Vitale, A ;
Bassanello, M ;
Boccagni, P ;
Brolese, A ;
Zanus, G ;
Burra, P ;
Fagiuoli, S ;
Farinati, F ;
Rugge, M ;
D'Amico, DF .
ANNALS OF SURGERY, 2004, 239 (02) :150-159
[10]   Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium [J].
Degroote, Helena ;
Callebout, Eduard ;
Iesari, Samuele ;
Dekervel, Jeroen ;
Schreiber, Jonas ;
Pirenne, Jacques ;
Verslype, Chris ;
Ysebaert, Dirk ;
Michielsen, Peter ;
Lucidi, Valerio ;
Moreno, Christophe ;
Detry, Olivier ;
Delwaide, Jean ;
Troisi, Roberto Ivan ;
Lerut, Jan Paul ;
Van Vlierberghe, Hans .
SURGICAL ONCOLOGY-OXFORD, 2020, 33 :231-238